Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
NCT01328756
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
314
Enrollment
INDUSTRY
Sponsor class
Conditions
Attention Deficit Hyperactivity Disorder (ADHD)
Interventions
DRUG:
Lisdexamfetamine dimesylate
Sponsor
Shire